Today: 30 January 2026
Subscribe
Browse Category

Investment Updates News 10 November 2025 - 27 November 2025

Capillary Technologies India Share Price Today, 27 November 2025: CAPILLARY Cools 3% After Fiery IPO Debut

Capillary Technologies India Share Price Today, 27 November 2025: CAPILLARY Cools 3% After Fiery IPO Debut

Capillary Technologies India Ltd (NSE: CAPILLARY, BSE: 544614) is seeing some profit‑booking on Thursday, 27 November 2025, after a high‑octane first week on the bourses. Around mid‑session, the SaaS company’s stock is trading in the ₹666–₹670 zone, down roughly 3–3.5% versus Wednesday’s close, but still comfortably above its IPO issue price of ₹577 per share. mint Below is a full…
27 November 2025
····
Ashtead Group (LON:AHT) Extends $1.5bn Buyback as US Listing Nears – 26 November 2025 Update

Ashtead Group (LON:AHT) Extends $1.5bn Buyback as US Listing Nears – 26 November 2025 Update

Ashtead Group plc, the FTSE 100 owner of Sunbelt Rentals, has kicked off Wednesday’s trading session with yet another share buyback announcement, underlining how central capital returns have become to the investment case ahead of its planned New York primary listing. Ashtead share price today: steady after four-day winning streak Ashtead shares were trading around 4,750–4,760p in London late morning…
26 November 2025
···
AT&T Stock Faces Crucial Test: 5G Spectrum Gamble, Fiber Expansion & Earnings Loom

AT&T Stock Today (T): Price Holds Up as Settlement Deadline Arrives and Vanguard Boosts Its Stake — November 18, 2025

AT&T stock is edging higher on Tuesday, November 18, 2025, as investors digest a major data‑breach settlement deadline, fresh institutional buying from Vanguard, and mixed Wall Street views — all against a backdrop of a global market sell‑off. Published: November 18, 2025 AT&T stock today: quick snapshot Price action: a defensive name in a shaky market Global markets are under…
18 November 2025
···
Light & Wonder (ASX:LNW): ASX‑Only Listing, $1.5bn Buyback Shift and Fresh Fund Moves – 17 November 2025 Update

Light & Wonder (ASX:LNW): ASX‑Only Listing, $1.5bn Buyback Shift and Fresh Fund Moves – 17 November 2025 Update

Light & Wonder, Inc. (ASX: LNW, formerly NASDAQ: LNW) has hit a turning point this week. As of 17 November 2025, the cross‑platform gaming group has fully completed its move to a sole listing on the Australian Securities Exchange (ASX), shifted its US$1.5 billion share buyback onto the Australian market, and attracted fresh attention from both institutional investors and brokers.…
17 November 2025
··
Rubico Inc. (RUBI) Stock Slides Again After $84 Million Fleet Refinancing — All the Key Updates for 13 November 2025

Rubico Inc. (RUBI) Stock Slides Again After $84 Million Fleet Refinancing — All the Key Updates for 13 November 2025

Rubico Inc. (NASDAQ: RUBI), the tiny Greek crude‑oil tanker owner that only began trading on Nasdaq in August, is back in the spotlight today after closing a major $84 million fleet refinancing — and still seeing its stock sink around the $0.20 level. Investing.com Australia The company has wrapped up sale‑and‑leaseback deals on both of its Suezmax tankers with a…
13 November 2025
···
Amazon Stock Skyrockets to Record High on AWS Boom – Analysts Predict More Upside

Amazon Stock Today (Nov. 11, 2025): AMZN Edges Higher as Amazon Ads Unboxed Debuts 315M‑Viewer Reach; Prime Video Adds The Game Awards & Soccer PPV

Snapshot: How AMZN Is Trading Today Amazon (NASDAQ: AMZN) was up about 0.4% at $249.30 in mid‑afternoon New York trading as of 2:36 p.m. ET. Regular U.S. stock trading hours are in effect on Veterans Day, though the U.S. bond market is closed.  MarketWatch Top Takeaways What’s Moving Amazon Stock Today 1) Amazon Ads unBoxed 2025: Audience Scale + AI Tools Amazon’s advertising unit…
11 November 2025
···
EME.L Soars on Duyung PSC Update: Empyrean Energy Jumps 90%+ as Conrad Asia Seeks Farm‑Down Completion (11 November 2025)

EME.L Soars on Duyung PSC Update: Empyrean Energy Jumps 90%+ as Conrad Asia Seeks Farm‑Down Completion (11 November 2025)

London — 11 November 2025 — Empyrean Energy Plc (AIM: EME) surged on Tuesday after the company flagged an operator update at Indonesia’s Mako Gas Field, part of the Duyung Production Sharing Contract (PSC). In a regulatory notice at 11:42 (UK time), Empyrean said operator Conrad Asia Energy placed its ASX‑listed securities in a trading halt pending an announcement “in…
11 November 2025
····
Galecto (GLTO) Soars on Damora Therapeutics Acquisition and $285M Financing: IND in 2026, Proof‑of‑Concept in 2027

Galecto (GLTO) Soars on Damora Therapeutics Acquisition and $285M Financing: IND in 2026, Proof‑of‑Concept in 2027

Galecto, Inc. (NASDAQ: GLTO) said this morning it completed the acquisition of Damora Therapeutics and closed a $284.9 million oversubscribed private placement, a one‑two punch that instantly refocuses the company on mutant calreticulin (mutCALR) therapies for myeloproliferative neoplasms (MPNs) and extends its cash runway into 2029. The announcement sent GLTO screaming higher in pre‑market trading. GlobeNewswire Key takeaways Why this…
10 November 2025
····
1 2 3 4

Stock Market Today

  • Electrosurgical Devices Market to Reach $9.25 Billion by 2033 on Aging Population and Tech Advances
    January 30, 2026, 7:49 AM EST. The global electrosurgical devices market is forecasted to grow from USD 6.92 billion in 2024 to USD 9.25 billion by 2033 at a 3.2% CAGR. Growth drivers include rising surgical volumes caused by aging populations and chronic diseases. Increasing adoption of minimally invasive surgeries, continuous technological improvements like advanced energy devices and safety features, and expanding healthcare expenditure in emerging markets also fuel demand. Enhanced clinical efficacy and safety help reduce intraoperative blood loss and procedure times. Investments in advanced devices rise as hospitals seek better outcomes for the growing elderly patient base, especially in regions with aging demographics such as Japan, Europe, and North America. The market outlook reflects rising needs due to chronic disease prevalence and increasing surgeries globally.
Go toTop